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The title compound, C26H26N2O7, is a thiamidine derivative.
Geometric parameters are in the usual ranges. The crystal
packing is stabilized by a classical N—H  O hydrogen bond,
several weak C—H  O hydrogen bonds and a – stacking
interaction.
Comment
The title compound, (I), is a derivative of thiamidine, an
intermediate in the preparation of zidovudine (AZT), the first
drug approved for the treatment of AIDS and HIV infection
(Mitsuya et al., 1990; De Clercq, 1994). It contains a ribose
unit, a pentose (five-carbon sugar) that is a component of
ribonucleic acid (RNA), where it alternates with phosphate
groups to form the back-bone of the RNA polymer and binds
to nitrogenous bases. It also contains thymine, a pyrimidine
base, linked to deoxyribose to form the nucleoside deoxy-
thymidine in animal cells. Thymidine is significant because of
its involvement in the biosynthesis of DNA and in the
preservation and transfer of genetic information. Nucleoside
derivatives are involved in important functions in cellular
metabolism and are used to synthesize enzyme inhibitors,
antiviral agents and anticancer agents (Yarchoan et al., 1989).
The present reaction is used to protect the hydroxyl groups
during the preparation of AZT. Recently, we reported the
crystal structure of a derivative of pyrimidine (Yathirajan et
al., 2007), and as a continuation of our research work on the
structures of bioactive molecules and drug intermediates, we
now report the crystal structure of (I), a new derivative of
thiamidine.
A perspective view of compound (I) is shown in Fig. 1. Bond
lengths and angles can be regarded as normal (Cambridge
Structural Database, Version 5.28, November 2006; MOGUL
Version 1.1; Allen, 2002; Bruno et al., 2004). The tetrahydro-
furan ring adopts an envelope conformation (Table 1), with
atoms C2, O1 C5 and C4 in a common plane and atom C3
deviating by 0.497 (3) A˚ from this plane. Both carboxylate
groups are only slightly twisted out of the plane of the para-
methylphenyl ring to which they are attached (Table 1).
An intermolecular N—H  O hydrogen bond (Table 2)
links the molecules into chains running along the b axis. The
crystal packing is further stabilized by weak C—H  O
hydrogen bonds (Table 2). In addition to these X—H  O
bonds, there is a – stacking interaction between the
dihydropyrimidine ring and the aromatic rings comprising
atoms C42–C47 at (12 + x, 32  y, 1  z) (centroid-to-centroid
distance 3.478 A˚) and at (12 + x,
3
2  y, 1  z) (centroid-to-
centroid distance 3.508 A˚). The N—H  O hydrogen bond
and the – stacking interaction are illustrated in Fig. 2.
Experimental
Toluoyl chloride (680 mg, 4.4 mmol) was added to a solution of
thymidine (485 mg, 2 mmol) in dry pyridine (10 ml). The solution was
stirred at room temperature for 2 h. The mixture was partitioned
between CHCl3 (50 ml) and 5% NaHCO3 (50 ml), and the organic
layer was collected, washed with 5% NaHCO3 (50 ml), dried over
anhydrous Na2SO4 and concentrated under reduced pressure. The
compound was crystallized from a solution in chloroform (m.p. 471–
473 K). Analysis for C26H26N2O7, found (calculated): C 65.16 (65.26),
H 5.39 (5.48), N: 5.76% (5.85%).
Crystal data
C26H26N2O7
Mr = 478.49
Orthorhombic, P212121
a = 6.4353 (4) A˚
b = 10.6994 (7) A˚
c = 34.373 (2) A˚
V = 2366.7 (3) A˚3
Z = 4
Mo K radiation
 = 0.10 mm1
T = 173 (2) K
0.41  0.37  0.21 mm
Data collection
Stoe IPDS II two-circle
diffractometer
Absorption correction: none
14101 measured reflections
2915 independent reflections
2617 reflections with I > 2(I)
Rint = 0.059
Refinement
R[F 2 > 2(F 2)] = 0.041
wR(F 2) = 0.109
S = 1.01
2915 reflections
324 parameters
H atoms treated by a mixture of
independent and constrained
refinement
max = 0.21 e A˚
3
min = 0.23 e A˚3
Table 1
Selected torsion angles ().
C5—O1—C2—C3 22.2 (2)
O1—C2—C3—C4 32.4 (2)
C2—C3—C4—C5 30.0 (2)
C2—O1—C5—C4 2.8 (2)
C3—C4—C5—O1 17.7 (2)
O41—C41—C42—C47 7.2 (3)
O42—C41—C42—C43 7.1 (3)
O61—C61—C62—C63 18.8 (3)
O62—C61—C62—C67 17.3 (4)
Table 2
Hydrogen-bond geometry (A˚, ).
D—H  A D—H H  A D  A D—H  A
N13—H13  O42i 0.88 (3) 1.96 (3) 2.842 (2) 175 (3)
C2—H2  O12 1.00 2.34 2.751 (2) 104
C6—H6A  O14ii 0.99 2.41 3.353 (2) 159
C16—H16  O61 0.95 2.59 3.473 (2) 156
C43—H43  O12ii 0.95 2.44 3.373 (2) 168
C68—H68B  O62iii 0.98 2.55 3.453 (4) 153
Symmetry codes: (i) x; y þ 1; z; (ii) x; y 1; z; (iii) xþ 1; yþ 12;zþ 12.
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Figure 1
The molecular structure of the title compound, with the atom numbering.
Displacement ellipsoids are drawn at the 50% probability level.
Figure 2
A packing diagram of the title compound. Only H atoms bonded to N are
shown. Hydrogen bonds are shown as dashed lines and – stacking
interactions as open dashed bonds.
In the absence of significant anomalous scattering effects, Friedel
pairs were merged. The absolute configuration was assigned arbi-
trarily. Carbon-bound H atoms were found in a difference map, but
they were refined using a riding model, with C—H = 0.95–1.00 A˚ and
Uiso(H) = 1.2Ueq(C) or 1.5Ueq(Cmethyl). The methyl groups were
allowed to rotate but not to tip. The amino H atom was freely refined.
Data collection: X-AREA (Stoe & Cie, 2001); cell refinement:
X-AREA; data reduction: X-AREA; program(s) used to solve
structure: SIR2002 (Burla et al., 2003); program(s) used to refine
structure: SHELXL97 (Sheldrick, 1997); molecular graphics:
PLATON (Spek, 2003) and XP in SHELXTL-Plus (Sheldrick, 1991);
software used to prepare material for publication: SHELXL97.
ANM thanks the University of Mysore for permission to
carry out this research work. BKS thanks AICTE, Govern-
ment of India, for financial assistance through the Career
Award for Young Teachers Scheme.
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